Table 5.

Comparison of causes of death 1 year after liver transplantation in patients with and without cryoprecipitate transfusion

Causes of death, n (%)	Without cryoprecipitate transfusion (n = 232)	With cryoprecipitate transfusion (n = 157)	Odds ratio (95 % CI)	p value
Liver related	12 (5.0)	10 (6.4)	1.2 (0.53, 3.0)	0.617
ARF related	4 (1.7)	10 (6.4)	3.9 (1.2, 12.6)	0.024*
Myocardial infarction	2 (0.9)	2 (1.3)	1.5 (0.21, 10.6)	0.695
Hypovolemic shock	2 (0.9)	4 (2.5)	3.0 (0.54, 16.6)	0.207
Acute lung injury/ARDS	3 (1.3)	1 (0.6)	0.49 (0.05, 4.7)	0.538
Pulmonary embolism	2 (0.9)	2 (1.3)	1.5 (0.21, 10.6)	0.695
Sepsis or MOF	7 (3.0)	5 (3.2)	1.1 (0.33, 3.4)	0.925
Malignancy	0 (0.0)	1 (0.6)
Unknown	1 (0.4)	2 (1.3)	3.0 (0.27, 33.2)	0.374
Total	33 (14.2)	37 (22.9)	1.8 (1.1, 3.0)	0.029*

There was a significant difference in ARF-related deaths between the two groups. More deaths within the first year after OLT were observed in the patients with cryoprecipitate transfusion

ARDS acute respiratory distress syndrome

* p value <0.05 indicates a significant difference between the two groups